SCHEMBL22179015

SCHEMBL22179015

[N-]=[N+]=NCCCCOc1ccc2c(c1)N(Cc1ccccc1)CN2Cc1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 1/20 0.37
▸ ABCG2 Q9UNQ0 2/20 0.36
▸ MAOB P27338 3/20 0.35
▸ MAOA P21397 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22366571 0.89 ABCG2 (0.46) GAAABCG2
SCHEMBL22179018 0.72 ADRB2 (0.36) ABCG2
SCHEMBL27522153 0.72 KCNA3 (0.61) —
Bromide SCHEMBL22366567 0.71 APAF1 (0.39) ABCG2
SCHEMBL29206245 0.70 KCNA3 (0.59) —
SCHEMBL15922743 0.70 KCNA3 (0.59) —
SCHEMBL15923485 0.70 KCNA3 (0.59) —
SCHEMBL14189705 0.70 KCNA3 (0.44) GAA
SCHEMBL14189707 0.69 KCNA3 (0.43) GAAMAOA
SCHEMBL22764566 0.67 KCNA3 (0.58) ABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3821982-B1 SUBSTRATE FOR NUCLEIC ACID AMPLIFICATION, AND METHOD FOR MANUFACTURING SAME KOREA RES INST BIOSCIENCE & BIOTECHNOLOGY (KR) 2024-07-10 — — EP disclosed
EP-3821981-B1 SUBSTRATE FOR NUCLEIC ACID AMPLIFICATION, AND METHOD FOR MANUFACTURING SAME KOREA RES INST BIOSCIENCE & BIOTECHNOLOGY (KR) 2024-07-10 — — EP disclosed
US-20210356461-A1 CARBENE COMPOUND, CARBENE-METAL NANOPARTICLE COMPLEX AND PREPARATION METHOD THEREOF KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2021-11-18 — — US disclosed
US-20210229104-A1 SUBSTRATE FOR NUCLEIC ACID AMPLIFICATION, AND METHOD FOR MANUFACTURING SAME KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2021-07-29 — — US disclosed
EP-3821982-A1 SUBSTRATE FOR NUCLEIC ACID AMPLIFICATION, AND METHOD FOR MANUFACTURING SAME Korea Research Institute of Bioscience and Biotechnology (KR) 2021-05-19 — — EP disclosed
EP-3821981-A1 SUBSTRATE FOR NUCLEIC ACID AMPLIFICATION, AND METHOD FOR MANUFACTURING SAME Korea Research Institute of Bioscience and Biotechnology (KR) 2021-05-19 — — EP disclosed
WO-2020138982-A1 GRAPHENE CHANNEL MEMBER COMPRISING CADAVERINE OLFACTORY RECEPTOR AND SENSOR COMPRISING SAME 한국생명공학연구원 2020-07-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210356461-A1 CARBENE COMPOUND, CARBENE-METAL NANOPARTICLE COMPLEX AND PREPARATION METHOD THEREOF MB, CLTB, PARN GAA 3153/4885ABCG2 4304/4885MAOB 2925/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback